HIMS Stock's Valuation Looks Reasonable As stated above, HIMS stock's valuation looks reasonable now. Let's use a reverse DCF, as I did in my HIMS article from November, to figure out how much ...
While Hims offers more options for sexual health and hair loss, Roman offers more options overall. Here’s our full breakdown of Hims vs. Roman for erectile dysfunction, hair loss, and more.
16don MSN
With Hims & Her's main source of growth set to be extinguished, Citi analysts said its full-year guidance appears "aspirational." ...
Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...
Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks ...
Hims & Hers Health (HIMS) is jumping 15% after the company announced that it had made an acquisition which will allow it to launch at-home lab testing. Hims & Hers owns and operates an online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback